Asiaticoside Combined With Carbon Ion Implantation to Improve the Biocompatibility of Silicone Rubber and to Reduce the Risk of Capsule Contracture.
Abstract
Capsular contracture caused by silicone rubber is a critical issue in plastic surgery that urgently needs to be solved. Studies have shown that carbon ion implant in silicone rubber (carbon silicone rubber, C-SR) can significantly improve the capsular structure, but the effect of this improvement only appear 2months or later. In this study, asiaticoside combined with carbon silicone rubber was used to explore the changes in the capsule to provide a reference for the treatment of capsule contracture. Human fibroblasts (HFF-1) were used for experiments. The combined effect of asiaticoside and carbon silicone rubber on cell proliferation was determined by the CCK8 method, cell migration changes were measured by Transwell assays, cell cycle changes were measured by flow cytometry, and the expression levels of fibroblast transformation markers (vimentin and α-SMA), collagen (Col-1A1) and TGF-β/Smad signaling pathway-related proteins (TGF-β1, TβRI, TβRII and Smad2/3) were detected by immunofluorescence. experiments were carried out by subcutaneous implantation of the material in SD rats, and asiaticoside was oral administered simultaneously. WB and ELISA were used to detect changes in the expression of TGF-β/Smad signaling pathway-related proteins. TGF-β/Smad signaling pathway proteins were then detected and confirmed by HE, Masson and immunohistochemical staining. The results shown that asiaticoside combined with carbon ion implantation inhibited the viability, proliferation and migration of fibroblasts on silicone rubber. immunofluorescence showed that the secretion levels of α-SMA and Col-1A1 were significantly decreased, the transformation of fibroblasts into myofibroblasts was weakened, and the TGF-β/Smad signaling pathway was inhibited. experimental results showed that asiaticoside combined with carbon silicone rubber inhibited TGF-β1 secretion and inhibited the TGF-β/Smad signaling pathway, reducing the thickness of the capsule and collagen deposition. These results imply that carbon silicone rubber combined with asiaticoside can regulate the viability, proliferation and migration of fibroblasts by inhibiting the TGF-β/Smad signaling pathway and reduce capsule thickness and collagen deposition, which greatly reduces the incidence of capsule contracture.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | Carbon Ion
|
scispacy | 1 | ||
| 해부 | HFF-1
|
scispacy | 1 | ||
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | fibroblast
|
scispacy | 1 | ||
| 해부 | oral
|
scispacy | 1 | ||
| 해부 | fibroblasts
|
scispacy | 1 | ||
| 해부 | myofibroblasts
|
scispacy | 1 | ||
| 해부 | subcutaneous
|
피하조직 | dict | 1 | |
| 합병증 | capsular contracture
|
피막구축 | dict | 1 | |
| 약물 | Asiaticoside
|
C0052506
asiaticoside
|
scispacy | 1 | |
| 약물 | Carbon
|
C0007009
Carbon
|
scispacy | 1 | |
| 약물 | Silicone
|
C0037114
silicones
|
scispacy | 1 | |
| 약물 | silicone rubber
|
C0037110
Silicone Elastomers
|
scispacy | 1 | |
| 약물 | carbon silicone
|
scispacy | 1 | ||
| 약물 | C-SR
|
scispacy | 1 | ||
| 약물 | CCK8
|
scispacy | 1 | ||
| 질환 | Contracture
|
C0009917
Contracture
|
scispacy | 1 | |
| 질환 | Capsule
|
scispacy | 1 | ||
| 기타 | capsular
|
scispacy | 1 | ||
| 기타 | Human fibroblasts
|
scispacy | 1 | ||
| 기타 | vimentin
|
scispacy | 1 | ||
| 기타 | collagen
|
scispacy | 1 | ||
| 기타 | Smad2/3
|
scispacy | 1 | ||
| 기타 | SD rats
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.
- Hyperhidrosis: Prevalence, Diagnosis, and Stepwise Treatment.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Venous thromboembolism prophylaxis regimen for patients undergoing deep inferior epigastric perforator flap breast reconstruction.
- Immediate one-stage subcutaneous breast reconstruction without ADM: A single-center 6-year experience.